EUVIMEDEUVIMED entdecken
Multizentrische Studie

Effects of Thymectomy in Late‐Onset Myasthenia Gravis: A Multi‐Center Longitudinal Retrospective Study

Jiaxin Chen iD, Chunhua Su iD, Li Feng, Haiyan Wang, Pei Chen, Chao Cheng, Xin Huang, Li Di, Hongxi Chen, Zhe Ruan iD, Ting Chang iD, Hongyu Zhou iD und 2 weitere

Annals of Neurology · 2026

DOI: 10.1002/ana.78093 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Neurology, 2026. Verfasst von Jiaxin Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Thymectomy, Myasthenia Gravis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Limited evidence has led to ongoing debate about the benefits of thymectomy for late‐onset myasthenia gravis (LOMG). This study aims to compare the outcomes of patients with LOMG who underwent thymectomy versus those who received medical treatment alone, and evaluate the incidence of surgical adverse events.

Methods

Non‐thymomatous acetylcholine‐receptor antibody positive patients with LOMG were selected from a multi‐center longitudinal clinical database. Rates of and time to response (remission and minimal manifestations status) were compared between 2 groups by propensity score matching (PSM), Kaplan–Meier analysis, and Cox regression models. Additionally, the incidence of adverse events about thymectomy was compared between LOMG and younger patients with myasthenia gravis (MG) aged 40 to 50 years old.

Results

A total of 55 and 210 patients with LOMG were enrolled in the thymectomy and medical treatment groups, respectively. The thymectomy group exhibited significantly younger onset age (56.31 ± 6.15 vs. 62.04 ± 7.83, p < 0.001). After PSM adjustment, thymectomy demonstrated a greater cumulative probability ( p < 0.001), and the 2.356‐fold (95% confidence interval [CI] = 1.537–3.612, p < 0.001) higher chance of better outcomes compared to medical treatment. In subgroup analysis, thymectomy showed significantly higher response rates compared to medical treatment alone at 24 ± 2 months (48.9%, 95% CI = 33.7–64.1% vs 23.8%, 95% CI = 14.2–33.3%, p = 0.004), and 36 ± 2 months (59.5%, 95% CI = 42.9–76.1% vs 28.9%, 95% CI = 18.5–39.4%, p = 0.002). The incidences of adverse events were comparable between patients with LOMG and younger patients with MG (32.0% vs 22.4%, p = 0.286).

Interpretation

Thymectomy may be an effective therapeutic option for LOMG. Our findings highlight the need for further development of a randomized trial targeting patients with LOMG. ANN NEUROL 2026;99:629–638

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThymectomyMyasthenia GravisHumansMiddle AgedMaleFemaleRetrospective StudiesLongitudinal StudiesAdultTreatment OutcomeAge of OnsetAged

Autor:innen und Institutionen

  • Department of Neurology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Guangdong Provincial Key Laboratory of Diagnosis and Treatment of Major Neurological Diseases, Guangzhou, China.
  • Department of Thoracic Surgery, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China.
  • Department of Neurology, West China Hospital, Sichuan University, Chengdu, China.
  • Department of Neurology, Tangdu Hospital, Air Force Medical University, Xi'an, Shaanxi, China.

ORCID-Profile: Jiaxin Chen, Chunhua Su, Zhe Ruan, Ting Chang, Hongyu Zhou, Yuwei Da

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Chen, J., Su, C., Feng, L., Wang, H., Chen, P., Cheng, C., Huang, X., Di, L., Chen, H., Ruan, Z., Chang, T., Zhou, H., Da, Y., & Feng, H. (2026). Effects of Thymectomy in Late‐Onset Myasthenia Gravis: A Multi‐Center Longitudinal Retrospective Study. Annals of Neurology. https://doi.org/10.1002/ana.78093

Vancouver

Chen J, Su C, Feng L, Wang H, Chen P, Cheng C, et al. Effects of Thymectomy in Late‐Onset Myasthenia Gravis: A Multi‐Center Longitudinal Retrospective Study. Annals of Neurology. 2026. doi:10.1002/ana.78093

BibTeX
@article{Chen2026,
  author = {Chen, Jiaxin and Su, Chunhua and Feng, Li and Wang, Haiyan and Chen, Pei and Cheng, Chao and Huang, Xin and Di, Li and Chen, Hongxi and Ruan, Zhe and Chang, Ting and Zhou, Hongyu and Da, Yuwei and Feng, Huiyu},
  title = {Effects of Thymectomy in Late‐Onset Myasthenia Gravis: A Multi‐Center Longitudinal Retrospective Study},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78093}
}
Kostenlos starten →